Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.1150
0.00 (0.00%)
Oct 1, 2026, 4:10 PM AEST
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 59.03 million as of October 1, 2026. Its market cap has decreased by -23.30% in one year.
Market Cap
59.03M
Enterprise Value
31.52M
Revenue
4.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
ChartMarket Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 59.03M, an increase of 71.12%. That is a compound annual growth rate of 4.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 59.03M | -23.30% |
| Dec 31, 2025 | 76.96M | 122.90% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | - |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 108.01M |
| Recce Pharmaceuticals | 94.79M |
| Alterity Therapeutics | 90.49M |
| LTR Pharma | 85.44M |
| Prescient Therapeutics | 70.45M |
| Avecho Biotechnology | 69.55M |
| Entropy Neurodynamics | 64.53M |
| Neurizon Therapeutics | 60.46M |